Cargando…
PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis
Loss-of-function variants of protein tyrosine phosphatase non-receptor type 2 (PTPN2) enhance risk of inflammatory bowel disease and rheumatoid arthritis; however, whether the association between PTPN2 and autoimmune arthritis depends on gut inflammation is unknown. Here we demonstrate that inductio...
Autores principales: | Hsieh, Wan-Chen, Svensson, Mattias N.D., Zoccheddu, Martina, Tremblay, Michael L., Sakaguchi, Shimon, Stanford, Stephanie M., Bottini, Nunzio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605542/ https://www.ncbi.nlm.nih.gov/pubmed/33055428 http://dx.doi.org/10.1172/jci.insight.141868 |
Ejemplares similares
-
Immunomodulatory Microparticles Epigenetically Modulate T Cells and Systemically Ameliorate Autoimmune Arthritis
por: McBride, David A., et al.
Publicado: (2023) -
Immunomodulatory Microparticles Epigenetically Modulate T Cells and Systemically Ameliorate Autoimmune Arthritis (Adv. Sci. 11/2023)
por: McBride, David A., et al.
Publicado: (2023) -
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
por: Sood, Shatakshi, et al.
Publicado: (2016) -
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders
por: Stanford, Stephanie M., et al.
Publicado: (2023) -
Autoimmunity linked protein phosphatase PTPN22 as a target for cancer immunotherapy
por: Cubas, Rafael, et al.
Publicado: (2020)